BREAKING NEWS

US COVID vaccine for children under 5 delayed by at least 2 months

A US decision on Pfizer and BioNTech's COVID-19 vaccine for infants and children 6 months through 4 years of age has been postponed for at least two months after the Food and Drug Administration (FDA) said it needed more data.

The FDA had planned to decide on the vaccine based on early trial data as soon as next week with the government planning to roll it out on Feb. 21. It had asked Pfizer to speed up its application as the Omicron variant of the coronavirus caused a surge of infections, including among children.



Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy